1,041
Views
11
CrossRef citations to date
0
Altmetric
Editorial

Monophosphoryl lipid A is an lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology

Pages 1639-1641 | Published online: 27 Sep 2013

Bibliography

  • Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 1992;256(5054):184-5
  • Herrmann N, Chau SA, Kircanski I, Lanctôt K. Current and emerging drug treatment options for Alzheimer's disease: a systematic review. Drugs 2011;71(15):2031-65
  • Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS beta-Amyloid in Alzheimer's disease. Science 2010;330(6012):1774
  • Lemere CA, Masliah E. Can Alzheimer disease be prevented by amyloid-[beta] immunotherapy? Nat Rev Neurol 2010;6(2):108-19
  • Rickman LS, Wistar R Jr, Hoffman SL, et al. Use of adjuvant containing mycobacterial cell-wall skeleton, monophosphoryl lipid A, and squalane in malaria circumsporozoite protein vaccine. Lancet 1991;337(8748):998-1001
  • McKeage K, Romanowski B. Spotlight on AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®). BioDrugs 2011;25(4):265-9
  • Qureshi N, Mascagni P, Ribi E, Takayama K. Monophosphoryl lipid A obtained from lipopolysaccharides of Salmonella minnesota R595. Purification of the dimethyl derivative by high performance liquid chromatography and complete structural determination. J Biol Chem 1985;260(9):5271-8
  • Michaud J-P, Hallé M, Lampron A, et al. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proc Natl Acad Sci 2013;110(5):1941-6
  • Mata-Haro V, Cekic C, Martin M, et al. The vaccine adjuvant monophosphoryl lipid a as a TRIF-biased agonist of TLR4. Science 2007;316(5831):1628-32
  • Chen G, Chen KS, Kobayashi D, et al. Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid. J Neurosci 2007;27(10):2654-62
  • Kofler J, Lopresti B, Janssen C, et al. Preventive immunization of aged and juvenile non-human primates to beta-amyloid. J Neuroinflammation 2012;9(1):84
  • Tayeb H, Murray E, Price B, Tarazi F. Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive? Expert Opin Biol Ther 2013;13(7):1075-84
  • Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992;42(3):631
  • Lee DC, Rizer J, Hunt JB, et al. Review: experimental manipulations of microglia in mouse models of Alzheimer's pathology: activation reduces amyloid but hastens tau pathology. Neuropathol Appl Neurobiol 2013;39(1):69-85
  • Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 2008;372(9634):216-23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.